The coxsackievirus and adenovirus receptor acts as a tumour suppressor in malignant glioma cells
Open Access
- 29 April 2003
- journal article
- research article
- Published by Springer Nature in British Journal of Cancer
- Vol. 88 (9) , 1411-1416
- https://doi.org/10.1038/sj.bjc.6600932
Abstract
The coxsackievirus and adenovirus receptor (CAR) is a membrane glycoprotein with a cytoplasmic domain, a transmembrane domain and an extracellular region consisting of two immunoglobulin-like domains, an amino-terminal immunoglobulin variable (IgV)-related domain (D1), which is distal to the cell surface, and a proximal IgC2 domain (D2). The coxsackievirus and adenovirus receptor has been shown to exhibit tumour suppression activity in human bladder and prostate cancer cells. In the current paper, we demonstrate that CAR is a tumour suppressor in glioma cells and that the extracellular D2 domain is not required for this inhibitory effect. This finding provides a biological basis for the observation that expression of CAR is downregulated in malignant glioma cells. This suggests that strategies to redirect adenoviruses to achieve CAR-independent infection will be necessary to realise the full potential of adenoviral vectors for cancer gene therapy.Keywords
This publication has 15 references indexed in Scilit:
- Expression of the coxsackie adenovirus receptor in normal prostate and in primary and metastatic prostate carcinoma: potential relevance to gene therapy.2002
- Targeted adenoviral vectorsBiochimica et Biophysica Acta (BBA) - Gene Structure and Expression, 2002
- The mechanism of the growth-inhibitory effect of coxsackie and adenovirus receptor (CAR) on human bladder cancer: a functional analysis of car protein structure.2001
- Genetic Targeting of an Adenovirus Vector via Replacement of the Fiber Protein with the Phage T4 FibritinJournal of Virology, 2001
- Dimeric Structure of the Coxsackievirus and Adenovirus Receptor D1 Domain at 1.7 Å ResolutionStructure, 2000
- The dual impact of coxsackie and adenovirus receptor expression on human prostate cancer gene therapy.2000
- Variability of adenovirus receptor density influences gene transfer efficiency and therapeutic response in head and neck cancer.1999
- Expression of Coxsackie adenovirus receptor and alphav-integrin does not correlate with adenovector targeting in vivo indicating anatomical vector barriersGene Therapy, 1999
- The Presence of Human Coxsackievirus and Adenovirus Receptor Is Associated with Efficient Adenovirus-Mediated Transgene Expression in Human Melanoma Cell CulturesHuman Gene Therapy, 1998
- Characteristics of a Human Cell Line Transformed by DNA from Human Adenovirus Type 5Journal of General Virology, 1977